Metoprine (2,4-diamino-5-(3,4-dichlorophenyl)-6-methylpyrimidine) is a dihydrofolate reductase (DHFR) inhibitor initially developed for potential applications in cancer treatment.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.